ARCHIVES

ImClone “Screwed Up,” CEO Waksal Tells Conference; Stock Plunges.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

An Adult Surgery Adapted To Children Increased Survival Of Rare Abdominal Cancer

May 28, 2010

FDA Committee Approves NDA for Mitxantrone

March 21, 1986

Pepper’s Legacy Included NCI, Other Biomedical Research

June 9, 1989

ACS Board allocated $37.5 Million to Research; More Coming

February 20, 1987

CCOP Letters Of Intent Reach 232; Frelick Experts 80-90 Percent Of them To Qualify For Applications

September 3, 1982

In The Courts: Lilly’s Claims Figured In Scripts Written To Coach Sales res, Court Documents Show

July 30, 1999